| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/22/2000 | EP0987263A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 03/22/2000 | EP0987250A1 Indole dicarboxylic acid derivatives |
| 03/22/2000 | EP0987239A1 Process for the preparation of alpha-substituted ringsystems |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0986382A1 Raf kinase inhibitors |
| 03/22/2000 | CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 03/22/2000 | CN1247865A Prepn. of quinolone and 1,8-diaza-naphthalenone carboxylic acid |
| 03/22/2000 | CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them |
| 03/21/2000 | US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability |
| 03/21/2000 | US6040331 Nerve cell protective agents |
| 03/21/2000 | US6040317 Sulfonamide fibrinogen receptor antagonists |
| 03/21/2000 | US6040289 Active drug treating obesity |
| 03/21/2000 | US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound |
| 03/21/2000 | CA2282885A1 New cationic 4-hydroxyindoles, their application in keratin fibre oxidation dye, dye compositions and dyeing methods |
| 03/21/2000 | CA2183731C Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 03/21/2000 | CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors |
| 03/16/2000 | WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | WO2000014063A1 Therapeutic compounds and methods |
| 03/16/2000 | WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders |
| 03/16/2000 | CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv |
| 03/15/2000 | EP0985666A1 Substituted indole compounds as COX-2 inhibitors |
| 03/15/2000 | EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity |
| 03/15/2000 | EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
| 03/15/2000 | EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists |
| 03/14/2000 | US6037500 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
| 03/14/2000 | US6037493 Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof |
| 03/14/2000 | US6037476 Contacting a cyclic carboxylic acid anhydride with a water soluble primary amine in the presence of a water soluble carboxylic acid and water; and allowing and/or causing the mixture to undergo reaction by hetaing to form cyclic imide |
| 03/14/2000 | US6037475 Reacting optionally substituted, n-protected indol-3-yl-acetamide with an alkyl oxalate and a strong organic base in a polar aprotic solvent forming optionally substituted 4-(indol-3-yl)-3-hydroxy pyrrole-2,5-dione |
| 03/14/2000 | US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis |
| 03/14/2000 | US6037362 Carbazole derivatives; deprotecting, amination; antilipemic and antidiabetic agents; b-adrenaline receptor agonists; dietetics |
| 03/14/2000 | US6037361 Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/09/2000 | WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 03/09/2000 | WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 03/09/2000 | WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 03/09/2000 | WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/09/2000 | DE19841985A1 New heterocyclic alkanesulfonic and alkane carboxylic acid derivatives are VEGF receptor blockers useful in treatment of e.g. psoriasis, rheumatoid arthritis, stroke, tumors and endometriosis |
| 03/09/2000 | DE19840108A1 Alpha-amino-cycloalkene preparation in quantitative yield by metathesis of amino-alkadiene, used as precursors for e.g. plant protectants, cyclohexylamine or sweeteners |
| 03/09/2000 | DE19840107A1 Verfahren zur Synthese alpha-substituierter Ringsysteme Method for the synthesis of alpha-substituted ring systems |
| 03/09/2000 | CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/09/2000 | CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 03/09/2000 | CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 03/08/2000 | EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
| 03/08/2000 | EP0983274A1 Phthalocyanine and use of phthalocyanine as a marking agent |
| 03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 03/08/2000 | EP0983264A1 Method of manufacturing sertindole |
| 03/08/2000 | EP0983247A1 Method for producing aromatic bisimides |
| 03/08/2000 | EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them |
| 03/08/2000 | EP0820275A4 Cosmetic melanins |
| 03/08/2000 | EP0591355B1 Porphycene compounds for photodynamic therapy |
| 03/08/2000 | CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them |
| 03/07/2000 | US6034216 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/07/2000 | US6034115 Indolyl-substituted phenylacetic acid derivatives |
| 03/07/2000 | US6034104 Anticoagulant agents |
| 03/03/2000 | CA2281227A1 Process for synthesizing .alpha.-substituted ring systems |
| 03/02/2000 | WO2000011001A1 Muscarinic agonists and antagonists |
| 03/02/2000 | WO2000010996A1 Inhibitors of bacterial nad synthetase |
| 03/02/2000 | WO2000010976A1 Substituted n-aryl-phthalimides |
| 03/02/2000 | WO2000010975A1 Oxindole derivatives as growth hormone releasers |
| 03/02/2000 | WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists |
| 03/02/2000 | WO1999064043A9 Muscarinic receptor antagonists |
| 03/02/2000 | CA2341506A1 Inhibitors of bacterial nad synthetase |
| 03/02/2000 | CA2340946A1 Muscarinic agonists and antagonists |
| 03/01/2000 | EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents |
| 03/01/2000 | CN1246117A 1,2-dihydroindene or indoline derivatives |
| 03/01/2000 | CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments |
| 03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
| 03/01/2000 | CN1049890C Process for extracting raw pyridine from coking ammonia water |
| 03/01/2000 | CN1049888C Process for preparing benzoylguanidine |
| 02/29/2000 | US6031130 Catalyzing the dehydration of a secondary amine compound by adding a rhenium catalyst and aqueous hydrogen peroxide to a mixture also containing a dehydrating agent; use as photographic developers, additives for polymers |
| 02/29/2000 | US6031111 Indolin-2-one derivatives |
| 02/29/2000 | US6031105 Substituted pyridines |
| 02/29/2000 | US6031099 Piperidine derivates having anxiolytic effect |
| 02/29/2000 | US6031097 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| 02/29/2000 | US6031003 Calcium receptor-active molecules |
| 02/29/2000 | US6030976 Use of sulfonamides |
| 02/29/2000 | US6030967 And/or like neurotrophic factor (for example, nerve growth factor (ngf), brain-derived neurotrophic factor, neurotrophin-3, and glial cell line-derived neurotrophic factor)-like activity; osteoporosis |
| 02/29/2000 | US6030966 Heterocyclic compound and their use |
| 02/29/2000 | US6030964 Binds to retinoic acid receptors and useful for treating psoriasis, autoimmune diseases, tumors, rheumatoid arthritis and for inducing immunosuppression in organ transplantation |
| 02/29/2000 | US6030952 As human and veterinary medicine, particularly in the treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmologic conditions, and in cosmetic compositions |
| 02/29/2000 | CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use |
| 02/24/2000 | WO2000009116A1 Grp receptor ligands |
| 02/24/2000 | WO2000009099A2 Treatment of vasodilatory headache |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | DE19849197C1 Selective, high yield lithiation of 5-membered heterocycle in presence of hydrogen acceptor, giving product useful as intermediate for plant protectants or drugs |
| 02/24/2000 | DE19837672A1 New N-(3-(alkylsulfonylamino)-phenyl)-phthalimide and N-(3-(arylsulfonylamino)-phenyl)-phthalimide derivatives useful as herbicides, especially for selective weed control in crops |
| 02/24/2000 | CA2340117A1 Treatment of vasodilatory headache |
| 02/23/2000 | CN1245491A 5-cyclo indole compounds as 5-HT receptor ligands |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028203 Phase transfer catalyzed method for prepared oxybisphthalic compounds |
| 02/22/2000 | US6028101 Fungicides for the control of take-all disease of plants |
| 02/22/2000 | US6028100 Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | US6027709 Fluorescent cyanine dyes |
| 02/22/2000 | CA2050352C Substituted 2-propenyl derivatives of nitrogen heterocycles |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000007986A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |